| # | Title | Journal | Year | Citations |
|---|
| 1 | EAU Guidelines on Interventional Treatment for Urolithiasis | European Urology | 2016 | 1,166 |
| 2 | EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 | European Urology | 2013 | 1,053 |
| 3 | European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update | European Urology | 2015 | 804 |
| 4 | European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update | European Urology | 2018 | 627 |
| 5 | EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis | European Urology | 2016 | 581 |
| 6 | Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 | European Urology | 2018 | 488 |
| 7 | Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes | European Urology | 2016 | 460 |
| 8 | Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy | Nature | 2015 | 451 |
| 9 | Is Benign Prostatic Hyperplasia (BPH) an Immune Inflammatory Disease? | European Urology | 2007 | 396 |
| 10 | Photodynamic Diagnosis of Non–muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data | European Urology | 2013 | 372 |
| 11 | Distribution of metastatic sites in patients with prostate cancer: A population‐based analysis | Prostate | 2014 | 352 |
| 12 | The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation | European Urology | 2011 | 351 |
| 13 | Are Small Renal Tumors Harmless? Analysis of Histopathological Features According to Tumors 4 Cm or Less in Diameter | Journal of Urology | 2006 | 307 |
| 14 | Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review | European Urology | 2014 | 277 |
| 15 | Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes | BJU International | 2014 | 274 |
| 16 | Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC) | World Journal of Urology | 2017 | 260 |
| 17 | Metabolic Evaluation and Recurrence Prevention for Urinary Stone Patients: EAU Guidelines | European Urology | 2015 | 246 |
| 18 | Reoperation, Myocardial Infarction and Mortality after Transurethral and Open Prostatectomy: A Nation-Wide, Long-Term Analysis of 23,123 Cases | European Urology | 2005 | 226 |
| 19 | Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel | European Urology | 2016 | 215 |
| 20 | Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up | Annals of Oncology | 2022 | 211 |
| 21 | Diagnostic Accuracy of Computed Tomography-Guided Percutaneous Biopsy of Renal Masses | European Urology | 2008 | 208 |
| 22 | A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy | European Urology | 2015 | 206 |
| 23 | Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review | European Urology | 2017 | 205 |
| 24 | Treatment of Localised Renal Cell Carcinoma | European Urology | 2011 | 198 |
| 25 | European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel | European Urology | 2021 | 198 |
| 26 | Hexyl Aminolevulinate–Guided Fluorescence Cystoscopy in the Diagnosis and Follow-up of Patients with Non–Muscle-invasive Bladder Cancer: A Critical Review of the Current Literature | European Urology | 2013 | 193 |
| 27 | Hypothyroidism in patients with renal cell carcinoma | Cancer | 2011 | 178 |
| 28 | More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer | European Urology | 2015 | 178 |
| 29 | Contemporary Management of Small Renal Masses | European Urology | 2011 | 164 |
| 30 | Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort | European Urology | 2014 | 156 |
| 31 | Characteristics and clinical significance of histological variants of bladder cancer | Nature Reviews Urology | 2017 | 147 |
| 32 | EAU Guidelines on Robotic and Single-site Surgery in Urology | European Urology | 2013 | 141 |
| 33 | Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling | Nature Communications | 2019 | 140 |
| 34 | EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort† | European Urology | 2020 | 132 |
| 35 | A Critical Analysis of the Actual Role of Minimally Invasive Surgery and Active Surveillance for Kidney Cancer | European Urology | 2010 | 130 |
| 36 | Could inflammation be a key component in the progression of benign prostatic hyperplasia? | Current Opinion in Urology | 2006 | 128 |
| 37 | Conditional Survival After Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over Time | European Urology | 2014 | 125 |
| 38 | Evaluation of chemiluminescence and flow cytometry as tools in assessing production of hydrogen peroxide and superoxide anion in human spermatozoa | Fertility and Sterility | 2009 | 122 |
| 39 | Prediction of Outcome Following Early Salvage Radiotherapy Among Patients with Biochemical Recurrence After Radical Prostatectomy | European Urology | 2014 | 121 |
| 40 | Tract Sizes in Miniaturized Percutaneous Nephrolithotomy: A Systematic Review from the European Association of Urology Urolithiasis Guidelines Panel | European Urology | 2017 | 119 |
| 41 | A Multinational, Multi-institutional Study Comparing Positive Surgical Margin Rates Among 22 393 Open, Laparoscopic, and Robot-assisted Radical Prostatectomy Patients | European Urology | 2014 | 116 |
| 42 | Impact of Medical Treatments for Male Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia on Ejaculatory Function: A Systematic Review and Meta-Analysis | Journal of Sexual Medicine | 2014 | 113 |
| 43 | ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma | Annals of Oncology | 2021 | 113 |
| 44 | PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical Impact | Clinical Cancer Research | 2018 | 112 |
| 45 | Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita | European Urology | 2020 | 112 |
| 46 | Laparoscopic Cryoablation Versus Partial Nephrectomy for the Treatment of Small Renal Masses: Systematic Review and Cumulative Analysis of Observational Studies | European Urology | 2011 | 106 |
| 47 | The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review | European Urology | 2018 | 105 |
| 48 | Human Dermis Harbors Distinct Mesenchymal Stromal Cell Subsets | Journal of Investigative Dermatology | 2012 | 103 |
| 49 | Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review | European Urology Focus | 2019 | 103 |
| 50 | Could inflammation be a key component in the progression of benign prostatic hyperplasia? | Current Opinion in Urology | 2006 | 103 |
